These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 11927004

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Suppression of occurrence and advancement of beta-catenin-accumulated crypts, possible premalignant lesions of colon cancer, by selective cyclooxygenase-2 inhibitor, celecoxib.
    Yamada Y, Yoshimi N, Hirose Y, Hara A, Shimizu M, Kuno T, Katayama M, Qiao Z, Mori H.
    Jpn J Cancer Res; 2001 Jun; 92(6):617-23. PubMed ID: 11429049
    [Abstract] [Full Text] [Related]

  • 3. Synergistic effects of (-)-epigallocatechin gallate with sulindac against colon carcinogenesis of rats treated with azoxymethane.
    Ohishi T, Kishimoto Y, Miura N, Shiota G, Kohri T, Hara Y, Hasegawa J, Isemura M.
    Cancer Lett; 2002 Mar 08; 177(1):49-56. PubMed ID: 11809530
    [Abstract] [Full Text] [Related]

  • 4. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
    Kishimoto Y, Morisawa T, Hosoda A, Shiota G, Kawasaki H, Hasegawa J.
    J Exp Clin Cancer Res; 2002 Jun 08; 21(2):203-11. PubMed ID: 12148579
    [Abstract] [Full Text] [Related]

  • 5. Effects of long-term administration of sulindac on APC mRNA and apoptosis in colons of rats treated with azoxymethane.
    Kishimoto Y, Yashima K, Morisawa T, Ohishi T, Marumoto A, Sano A, Idobe-Fujii Y, Miura N, Shiota G, Murawaki Y, Hasegawa J.
    J Cancer Res Clin Oncol; 2002 Nov 08; 128(11):589-95. PubMed ID: 12458338
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sequential analysis of morphological and biological properties of beta-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis.
    Yamada Y, Yoshimi N, Hirose Y, Matsunaga K, Katayama M, Sakata K, Shimizu M, Kuno T, Mori H.
    Cancer Res; 2001 Mar 01; 61(5):1874-8. PubMed ID: 11280741
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis.
    Reddy BS, Rao CV, Seibert K.
    Cancer Res; 1996 Oct 15; 56(20):4566-9. PubMed ID: 8840961
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Azoxymethane-induced beta-catenin-accumulated crypts in colonic mucosa of rodents as an intermediate biomarker for colon carcinogenesis.
    Hirose Y, Kuno T, Yamada Y, Sakata K, Katayama M, Yoshida K, Qiao Z, Hata K, Yoshimi N, Mori H.
    Carcinogenesis; 2003 Jan 15; 24(1):107-11. PubMed ID: 12538355
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Suppression of azoxymethane-induced rat colon aberrant crypt foci by dietary protocatechuic acid.
    Kawamori T, Tanaka T, Kojima T, Suzui M, Ohnishi M, Mori H.
    Jpn J Cancer Res; 1994 Jul 15; 85(7):686-91. PubMed ID: 8071110
    [Abstract] [Full Text] [Related]

  • 14. Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac.
    Agarwal B, Rao CV, Bhendwal S, Ramey WR, Shirin H, Reddy BS, Holt PR.
    Gastroenterology; 1999 Oct 15; 117(4):838-47. PubMed ID: 10500066
    [Abstract] [Full Text] [Related]

  • 15. Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis.
    Yamada Y, Yoshimi N, Hirose Y, Kawabata K, Matsunaga K, Shimizu M, Hara A, Mori H.
    Cancer Res; 2000 Jul 01; 60(13):3323-7. PubMed ID: 10910031
    [Abstract] [Full Text] [Related]

  • 16. Tumor formation is correlated with expression of beta-catenin-accumulated crypts in azoxymethane-induced colon carcinogenesis in mice.
    Hata K, Yamada Y, Kuno T, Hirose Y, Hara A, Qiang SH, Mori H.
    Cancer Sci; 2004 Apr 01; 95(4):316-20. PubMed ID: 15072589
    [Abstract] [Full Text] [Related]

  • 17. Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis.
    Femia AP, Dolara P, Caderni G.
    Carcinogenesis; 2004 Feb 01; 25(2):277-81. PubMed ID: 14604897
    [Abstract] [Full Text] [Related]

  • 18. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV, Indranie C, Simi B, Manning PT, Connor JR, Reddy BS.
    Cancer Res; 2002 Jan 01; 62(1):165-70. PubMed ID: 11782374
    [Abstract] [Full Text] [Related]

  • 19. Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process.
    Reddy BS, Kawamori T, Lubet RA, Steele VE, Kelloff GJ, Rao CV.
    Cancer Res; 1999 Jul 15; 59(14):3387-91. PubMed ID: 10416599
    [Abstract] [Full Text] [Related]

  • 20. The modifying effect of Peucedanum japonicum, a herb in the Ryukyu Islands, on azoxymethane-induced colon preneoplastic lesions in male F344 rats.
    Morioka T, Suzui M, Nabandith V, Inamine M, Aniya Y, Nakayama T, Ichiba T, Mori H, Yoshimi N.
    Cancer Lett; 2004 Mar 18; 205(2):133-41. PubMed ID: 15036645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.